有価証券レコード · アーカイブ済み四半期

LLY

Eli Lilly and Company · Healthcare · Drug Manufacturers - General

1,233.5 -1.1% 時価総額 $1.16T 株価は遅延表示（FMP） · 時点 Aug 25 22:08 UTC — 下記ファイリングデータとは別個

Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024

193追跡対象保有者

+2Δ保有者数

707.04M保有株数

$758.81B報告済み評価額

+3新規ポジション

−0解消銘柄

Stable コンビクションスコア 55/100 3 追跡株式数が増加した四半期数 ●●●○○○ 算出方法 → リサーチデスクで解説する →

モメンタム指標（同類マネージャー）：保有者の広がり +1.0% · 株式フロー -0.6% · 新規ネットポジション数 +1.6% — 計算式
保有の分散化 — 保有者数の増加、合計持分の縮小

すべての保有状況データ：追跡対象13Fマネージャーのみ、普通株ポジション、報告期間 Q4 2025

保有状況の推移

四半期	保有者	Δ	株数	報告済み評価額	新規	解消銘柄
Q2 2026	193	+4	671.92M	$804.91B	+6	−1
Q1 2026	191	-3	666.59M	$613.20B	+1	−5
Q4 2025	193	+2	707.04M	$758.81B	+3	—
Q3 2025	27	-3	329.88M	$251.63B	+2	−6
Q2 2025	28	-1	307.45M	$239.60B	+2	−3
Q1 2025	26	0	140.32M	$115.83B	+1	−1
Q4 2024	26	+1	145.00M	$111.91B	+3	−2
Q3 2024	24	+2	109.89M	$97.29B	+2	—
Q2 2024	22	—	112.43M	$101.75B	—	—

保有者数

保有者情報 · Q4 2025

#	運用会社	株数	Δ株式数	時価	そのウェイト		保有中
1	Lilly Endowment Inc	92.19M	—	$99.08B	100.0%	n/c	1	SEC ↗
2	The Vanguard Group ✦ (パッシブ)	81.97M	+1.2%	$88.09B	1.3%	▲ Add	3	SEC ↗
3	The Vanguard Group ✦ (パッシブ)	81.97M	+1.2%	$88.09B	1.3%	▲ Add	3	SEC ↗
4	The Vanguard Group ✦ (パッシブ)	81.97M	+1.2%	$88.09B	1.3%	▲ Add	3	SEC ↗
5	The Vanguard Group ✦ (パッシブ)	81.97M	+1.2%	$88.09B	1.3%	▲ Add	3	SEC ↗
6	The Vanguard Group ✦ (パッシブ)	81.97M	+1.2%	$88.09B	1.3%	▲ Add	3	SEC ↗
7	The Vanguard Group ✦ (パッシブ)	81.97M	+1.2%	$88.09B	1.3%	▲ Add	3	SEC ↗
8	The Vanguard Group ✦ (パッシブ)	81.97M	+1.2%	$88.09B	1.3%	▲ Add	3	SEC ↗
9	BlackRock ✦ (パッシブ)	66.79M	+1.5%	$71.78B	1.2%	▲ Add	3	SEC ↗
10	BlackRock ✦ (パッシブ)	66.79M	+1.5%	$71.78B	1.2%	▲ Add	3	SEC ↗
11	BlackRock ✦ (パッシブ)	66.79M	+1.5%	$71.78B	1.2%	▲ Add	3	SEC ↗
12	BlackRock ✦ (パッシブ)	66.79M	+1.5%	$71.78B	1.2%	▲ Add	3	SEC ↗
13	BlackRock ✦ (パッシブ)	66.79M	+1.5%	$71.78B	1.2%	▲ Add	3	SEC ↗
14	BlackRock ✦ (パッシブ)	66.79M	+1.5%	$71.78B	1.2%	▲ Add	3	SEC ↗
15	BlackRock ✦ (パッシブ)	66.79M	+1.5%	$71.78B	1.2%	▲ Add	3	SEC ↗
16	BlackRock ✦ (パッシブ)	66.79M	+1.5%	$71.78B	1.2%	▲ Add	3	SEC ↗
17	BlackRock ✦ (パッシブ)	66.79M	+1.5%	$71.78B	1.2%	▲ Add	3	SEC ↗
18	BlackRock ✦ (パッシブ)	66.79M	+1.5%	$71.78B	1.2%	▲ Add	3	SEC ↗
19	BlackRock ✦ (パッシブ)	66.79M	+1.5%	$71.78B	1.2%	▲ Add	3	SEC ↗
20	BlackRock ✦ (パッシブ)	66.79M	+1.5%	$71.78B	1.2%	▲ Add	3	SEC ↗
21	BlackRock ✦ (パッシブ)	66.79M	+1.5%	$71.78B	1.2%	▲ Add	3	SEC ↗
22	BlackRock ✦ (パッシブ)	66.79M	+1.5%	$71.78B	1.2%	▲ Add	3	SEC ↗
23	BlackRock ✦ (パッシブ)	66.79M	+1.5%	$71.78B	1.2%	▲ Add	3	SEC ↗
24	BlackRock ✦ (パッシブ)	66.79M	+1.5%	$71.78B	1.2%	▲ Add	3	SEC ↗
25	BlackRock ✦ (パッシブ)	66.79M	+1.5%	$71.78B	1.2%	▲ Add	3	SEC ↗
26	BlackRock ✦ (パッシブ)	66.79M	+1.5%	$71.78B	1.2%	▲ Add	3	SEC ↗
27	BlackRock ✦ (パッシブ)	66.79M	+1.5%	$71.78B	1.2%	▲ Add	3	SEC ↗
28	BlackRock ✦ (パッシブ)	66.79M	+1.5%	$71.78B	1.2%	▲ Add	3	SEC ↗
29	BlackRock ✦ (パッシブ)	66.79M	+1.5%	$71.78B	1.2%	▲ Add	3	SEC ↗
30	BlackRock ✦ (パッシブ)	66.79M	+1.5%	$71.78B	1.2%	▲ Add	3	SEC ↗
31	BlackRock ✦ (パッシブ)	66.79M	+1.5%	$71.78B	1.2%	▲ Add	3	SEC ↗
32	BlackRock ✦ (パッシブ)	66.79M	+1.5%	$71.78B	1.2%	▲ Add	3	SEC ↗
33	Pnc Financial Services Group, Inc.	51.33M	—	$55.17B	30.1%	n/c	1	SEC ↗
34	Pnc Financial Services Group, Inc.	51.33M	—	$55.17B	30.1%	n/c	1	SEC ↗
35	Pnc Financial Services Group, Inc.	51.33M	—	$55.17B	30.1%	n/c	1	SEC ↗
36	Pnc Financial Services Group, Inc.	51.33M	—	$55.17B	30.1%	n/c	1	SEC ↗
37	Pnc Financial Services Group, Inc.	51.33M	—	$55.17B	30.1%	n/c	1	SEC ↗
38	Pnc Financial Services Group, Inc.	51.33M	—	$55.17B	30.1%	n/c	1	SEC ↗
39	Pnc Financial Services Group, Inc.	51.33M	—	$55.17B	30.1%	n/c	1	SEC ↗
40	Pnc Financial Services Group, Inc.	51.33M	—	$55.17B	30.1%	n/c	1	SEC ↗
41	Pnc Financial Services Group, Inc.	51.33M	—	$55.17B	30.1%	n/c	1	SEC ↗
42	Pnc Financial Services Group, Inc.	51.33M	—	$55.17B	30.1%	n/c	1	SEC ↗
43	Pnc Financial Services Group, Inc.	51.33M	—	$55.17B	30.1%	n/c	1	SEC ↗
44	State Street Global Advisors ✦ (パッシブ)	35.36M	+1.8%	$38.00B	1.3%	▲ Add	5	SEC ↗
45	Fidelity (FMR) ✦	25.72M	+6.4%	$27.64B	1.4%	▲ Add	3	SEC ↗
46	Fidelity (FMR) ✦	25.72M	+6.4%	$27.64B	1.4%	▲ Add	3	SEC ↗
47	Fidelity (FMR) ✦	25.72M	+6.4%	$27.64B	1.4%	▲ Add	3	SEC ↗
48	Fidelity (FMR) ✦	25.72M	+6.4%	$27.64B	1.4%	▲ Add	3	SEC ↗
49	Fidelity (FMR) ✦	25.72M	+6.4%	$27.64B	1.4%	▲ Add	3	SEC ↗
50	Fidelity (FMR) ✦	25.72M	+6.4%	$27.64B	1.4%	▲ Add	3	SEC ↗
51	Capital Research Global Investors	24.57M	—	$26.40B	4.9%	n/c	1	SEC ↗
52	Geode Capital Management ✦ (パッシブ)	19.81M	0.0%	$21.22B	1.3%	▼ Trim	7	SEC ↗
53	Geode Capital Management ✦ (パッシブ)	19.81M	0.0%	$21.22B	1.3%	▼ Trim	7	SEC ↗
54	Morgan Stanley ✦	15.59M	+2.7%	$16.76B	1.0%	▲ Add	2	SEC ↗
55	Morgan Stanley ✦	15.59M	+2.7%	$16.76B	1.0%	▲ Add	2	SEC ↗
56	Morgan Stanley ✦	15.59M	+2.7%	$16.76B	1.0%	▲ Add	2	SEC ↗
57	Morgan Stanley ✦	15.59M	+2.7%	$16.76B	1.0%	▲ Add	2	SEC ↗
58	Morgan Stanley ✦	15.59M	+2.7%	$16.76B	1.0%	▲ Add	2	SEC ↗
59	Morgan Stanley ✦	15.59M	+2.7%	$16.76B	1.0%	▲ Add	2	SEC ↗
60	Morgan Stanley ✦	15.59M	+2.7%	$16.76B	1.0%	▲ Add	2	SEC ↗
61	Morgan Stanley ✦	15.59M	+2.7%	$16.76B	1.0%	▲ Add	2	SEC ↗
62	Morgan Stanley ✦	15.59M	+2.7%	$16.76B	1.0%	▲ Add	2	SEC ↗
63	Morgan Stanley ✦	15.59M	+2.7%	$16.76B	1.0%	▲ Add	2	SEC ↗
64	Morgan Stanley ✦	15.59M	+2.7%	$16.76B	1.0%	▲ Add	2	SEC ↗
65	Morgan Stanley ✦	15.59M	+2.7%	$16.76B	1.0%	▲ Add	2	SEC ↗
66	Morgan Stanley ✦	15.59M	+2.7%	$16.76B	1.0%	▲ Add	2	SEC ↗
67	Morgan Stanley ✦	15.59M	+2.7%	$16.76B	1.0%	▲ Add	2	SEC ↗
68	Morgan Stanley ✦	15.59M	+2.7%	$16.76B	1.0%	▲ Add	2	SEC ↗
69	Morgan Stanley ✦	15.59M	+2.7%	$16.76B	1.0%	▲ Add	2	SEC ↗
70	Morgan Stanley ✦	15.59M	+2.7%	$16.76B	1.0%	▲ Add	2	SEC ↗
71	Morgan Stanley ✦	15.59M	+2.7%	$16.76B	1.0%	▲ Add	2	SEC ↗
72	Morgan Stanley ✦	15.59M	+2.7%	$16.76B	1.0%	▲ Add	2	SEC ↗
73	Morgan Stanley ✦	15.59M	+2.7%	$16.76B	1.0%	▲ Add	2	SEC ↗
74	Morgan Stanley ✦	15.59M	+2.7%	$16.76B	1.0%	▲ Add	2	SEC ↗
75	Morgan Stanley ✦	15.59M	+2.7%	$16.76B	1.0%	▲ Add	2	SEC ↗
76	Morgan Stanley ✦	15.59M	+2.7%	$16.76B	1.0%	▲ Add	2	SEC ↗
77	Morgan Stanley ✦	15.59M	+2.7%	$16.76B	1.0%	▲ Add	2	SEC ↗
78	Capital World Investors ✦	15.03M	+0.4%	$16.15B	2.2%	▲ Add	7	SEC ↗
79	T. Rowe Price ✦	14.91M	+10.6%	$16.02B	1.7%	▲ Add	7	SEC ↗
80	T. Rowe Price ✦	14.91M	+10.6%	$16.02B	1.7%	▲ Add	7	SEC ↗
81	Wellington Management ✦	13.36M	-8.3%	$14.35B	2.5%	▼ Trim	7	SEC ↗
82	Wellington Management ✦	13.36M	-8.3%	$14.35B	2.5%	▼ Trim	7	SEC ↗
83	Wellington Management ✦	13.36M	-8.3%	$14.35B	2.5%	▼ Trim	7	SEC ↗
84	Wellington Management ✦	13.36M	-8.3%	$14.35B	2.5%	▼ Trim	7	SEC ↗
85	Wellington Management ✦	13.36M	-8.3%	$14.35B	2.5%	▼ Trim	7	SEC ↗
86	Wellington Management ✦	13.36M	-8.3%	$14.35B	2.5%	▼ Trim	7	SEC ↗
87	Wellington Management ✦	13.36M	-8.3%	$14.35B	2.5%	▼ Trim	7	SEC ↗
88	Wellington Management ✦	13.36M	-8.3%	$14.35B	2.5%	▼ Trim	7	SEC ↗
89	Wellington Management ✦	13.36M	-8.3%	$14.35B	2.5%	▼ Trim	7	SEC ↗
90	JPMorgan Chase ✦	13.00M	-36.7%	$13.97B	0.9%	▼ Trim	2	SEC ↗
91	JPMorgan Chase ✦	13.00M	-36.7%	$13.97B	0.9%	▼ Trim	2	SEC ↗
92	JPMorgan Chase ✦	13.00M	-36.7%	$13.97B	0.9%	▼ Trim	2	SEC ↗
93	JPMorgan Chase ✦	13.00M	-36.7%	$13.97B	0.9%	▼ Trim	2	SEC ↗
94	JPMorgan Chase ✦	13.00M	-36.7%	$13.97B	0.9%	▼ Trim	2	SEC ↗
95	JPMorgan Chase ✦	13.00M	-36.7%	$13.97B	0.9%	▼ Trim	2	SEC ↗
96	JPMorgan Chase ✦	13.00M	-36.7%	$13.97B	0.9%	▼ Trim	2	SEC ↗
97	JPMorgan Chase ✦	13.00M	-36.7%	$13.97B	0.9%	▼ Trim	2	SEC ↗
98	JPMorgan Chase ✦	13.00M	-36.7%	$13.97B	0.9%	▼ Trim	2	SEC ↗
99	JPMorgan Chase ✦	13.00M	-36.7%	$13.97B	0.9%	▼ Trim	2	SEC ↗
100	JPMorgan Chase ✦	13.00M	-36.7%	$13.97B	0.9%	▼ Trim	2	SEC ↗

「当該ウェイト」= そのマネージャーの報告済み13F株式評価額に占めるポジションの割合（確信度の指標）。✦ = キュレーション済みマネージャー。

新規買い手

今四半期は新規追跡買い手がいません。

ポジション解消済み

今四半期は追跡されたエグジットがありません。

市場全体のコンテキスト: 全13Fファイラー対象（SEC構造化データ、 Q1 2026): 4,323 保有者, 762.84M 株式数, $674.93B 報告済み. これは上記の追跡対象ユニバースの数値とは異なる、より古い期間のものであり、両者が混在することはありません。

共同保有が多い銘柄

この有価証券の追跡対象保有者が最も頻繁に保有する他の銘柄 — ファンダメンタルな関係ではなく、共同保有件数に基づきます。

AMZN191共有保有者 MSFT190共有保有者 GOOGL189共有保有者 NVDA187共有保有者 META187共有保有者

インサイダー取引

市場内買い付け (P)

カバレッジ期間内にインサイダーによる市場内買い付けはありません。

市場内売却 (S)

Aug 17 Jonsson Patrik

Officer · 6.50K 株 · $7.64M

Aug 10 Zakrowski Donald A

Officer · 2.00K 株 · $2.37M

Aug 07 Hakim Anat

Officer · 5.00K 株 · $5.95M

株式付与、権利行使および税務目的の株式差し引きは、買いや売りとして集計しません。方法論

実質的所有権

Jul 23 SC 13G/A — LILLY ENDOWMENT INC

SECオリジナル提出書類を表示 ↗

ニュース

Aug 24 FDA Clears Roche And Eli Lilly's Alzheimer's Blood Test ↗

The Food and Drug Administration has cleared a new blood test from Roche and Eli Lilly designed to help identify…

Forbes

Aug 24 FDA Approves Alzheimer's Blood Test Developed by Roche and Eli Lilly ↗

The Food and Drug Administration cleared a blood test for identifying Alzheimer's disease symptoms, which was developed…

WSJ

Aug 24 Roche, Eli Lilly's Alzheimer's blood test gets FDA clearance ↗

The U.S. Food and Drug Administration has cleared Roche and partner Eli Lilly's blood test to help identify signs of…

Reuters

Aug 24 Eli Lilly Launches Foundayo Weight-Loss Pill in U.K. ↗

The once-daily pill was approved for patients with a body mass index of at least 30, or between 27 and 30 in the event…

WSJ

Aug 23 Eli Lilly launches oral weight-loss pill Foundayo in UK ↗

Eli Lilly said on Monday it has launched its oral pill, Foundayo, in the UK for weight ‌management and type 2…